articleJournal of Clinical InvestigationJul 15, 2005BRONZE OA

The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages

University of Münster · German Cancer Research Center · +5 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Biglycan, a small leucine-rich proteoglycan, is a ubiquitous ECM component; however, its biological role has not been elucidated in detail. Here we show that biglycan acts in macrophages as an endogenous ligand of TLR4 and TLR2, which mediate innate immunity, leading to rapid activation of p38, ERK, and NF-kappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2). In agreement, the stimulatory effects of biglycan are significantly reduced in TLR4-mutant (TLR4-M), TLR2-/-, and myeloid differentiation factor 88-/- (MyD88-/-) macrophages and completely abolished in TLR2-/-/TLR4-M macrophages. Biglycan-null mice have a considerable survival benefit in LPS- or…

Citation impact

836
total citations
FWCI
8.90
Percentile
100%
References
59
Citations per year

Authors

13

Topics & keywords

Keywords
  • Biglycan
  • Proinflammatory cytokine
  • TLR2
  • TLR4
  • Cell biology
  • Toll-like receptor
  • Innate immune system
  • Inflammation
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding